ReviewCells2025
Targeting the CXCR4/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer.
Desh Deepak Singh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewCells2025
Desh Deepak Singh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.